<SEC-DOCUMENT>0001398344-25-019284.txt : 20251017
<SEC-HEADER>0001398344-25-019284.hdr.sgml : 20251017
<ACCEPTANCE-DATETIME>20251017171052
ACCESSION NUMBER:		0001398344-25-019284
CONFORMED SUBMISSION TYPE:	SCHEDULE 13D/A
PUBLIC DOCUMENT COUNT:		2
FILED AS OF DATE:		20251017
DATE AS OF CHANGE:		20251017

SUBJECT COMPANY:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			NovaBay Pharmaceuticals, Inc.
		CENTRAL INDEX KEY:			0001389545
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				680454536
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		SCHEDULE 13D/A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	005-83670
		FILM NUMBER:		251401511

	BUSINESS ADDRESS:	
		STREET 1:		2000 POWELL STREET, SUITE 1150
		CITY:			EMERYVILLE
		STATE:			CA
		ZIP:			94608
		BUSINESS PHONE:		(510) 899-8800

	MAIL ADDRESS:	
		STREET 1:		2000 POWELL STREET, SUITE 1150
		CITY:			EMERYVILLE
		STATE:			CA
		ZIP:			94608

FILED BY:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			POPLAR POINT CAPITAL MANAGEMENT LLC
		CENTRAL INDEX KEY:			0001588273
		ORGANIZATION NAME:           	
		EIN:				460530967
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		SCHEDULE 13D/A

	BUSINESS ADDRESS:	
		STREET 1:		330 PRIMROSE ROAD, SUITE 400
		CITY:			BURLINGAME
		STATE:			CA
		ZIP:			94010
		BUSINESS PHONE:		650-239-9049

	MAIL ADDRESS:	
		STREET 1:		330 PRIMROSE ROAD, SUITE 400
		CITY:			BURLINGAME
		STATE:			CA
		ZIP:			94010
</SEC-HEADER>
<DOCUMENT>
<TYPE>SCHEDULE 13D/A
<SEQUENCE>1
<FILENAME>primary_doc.xml
<TEXT>
<XML>
<?xml version="1.0" encoding="UTF-8"?><edgarSubmission xmlns="http://www.sec.gov/edgar/schedule13D" xmlns:com="http://www.sec.gov/edgar/common">
  <headerData>
    <submissionType>SCHEDULE 13D/A</submissionType>
    <filerInfo>
      <filer>
        <filerCredentials>
          <!-- Field: Pseudo-Tag; ID: Name; Data: POPLAR POINT CAPITAL MANAGEMENT LLC -->
          <cik>0001588273</cik>
          <ccc>XXXXXXXX</ccc>
        </filerCredentials>
      </filer>
      <liveTestFlag>LIVE</liveTestFlag>


    </filerInfo>
  </headerData>
  <formData>
    <coverPageHeader>
      <amendmentNo>2</amendmentNo>
      <securitiesClassTitle>Common Stock, par value $0.01 per share</securitiesClassTitle>
      <dateOfEvent>10/15/2025</dateOfEvent>
      <previouslyFiledFlag>true</previouslyFiledFlag>
      <issuerInfo>
        <issuerCIK>0001389545</issuerCIK>
        <issuerCUSIP>66987P409</issuerCUSIP>
        <issuerName>Novabay Pharmaceuticals, Inc.</issuerName>
        <address>
          <com:street1>2000 Powell Street</com:street1>
          <com:street2>Suite 1150</com:street2>
          <com:city>Emeryville</com:city>
          <com:stateOrCountry>CA</com:stateOrCountry>
          <com:zipCode>94608</com:zipCode>
        </address>
      </issuerInfo>
      <authorizedPersons>
        <notificationInfo>
          <personName>Jad Fakhry</personName>
          <personPhoneNum>650-239-9049</personPhoneNum>
          <personAddress>
            <com:street1>330 Primrose Road</com:street1>
            <com:street2>Suite 400</com:street2>
            <com:city>Burlingame</com:city>
            <com:stateOrCountry>CA</com:stateOrCountry>
            <com:zipCode>94010</com:zipCode>
          </personAddress>
        </notificationInfo>
      </authorizedPersons>
    </coverPageHeader>
    <reportingPersons>
      <reportingPersonInfo>
        <reportingPersonCIK>0001588273</reportingPersonCIK>
        <reportingPersonNoCIK>N</reportingPersonNoCIK>
        <reportingPersonName>Poplar Point Capital Management LLC</reportingPersonName>
        <fundType>WC</fundType>
        <legalProceedings>N</legalProceedings>
        <citizenshipOrOrganization>DE</citizenshipOrOrganization>
        <soleVotingPower>0.00</soleVotingPower>
        <sharedVotingPower>1020300.00</sharedVotingPower>
        <soleDispositivePower>0.00</soleDispositivePower>
        <sharedDispositivePower>1020300.00</sharedDispositivePower>
        <aggregateAmountOwned>1020300.00</aggregateAmountOwned>
        <isAggregateExcludeShares>N</isAggregateExcludeShares>
        <percentOfClass>17.52</percentOfClass>
        <typeOfReportingPerson>IA</typeOfReportingPerson>
      </reportingPersonInfo>
      <reportingPersonInfo>
        <reportingPersonCIK>0001588289</reportingPersonCIK>
        <reportingPersonNoCIK>N</reportingPersonNoCIK>
        <reportingPersonName>Poplar Point Capital Partners LP</reportingPersonName>
        <fundType>WC</fundType>
        <legalProceedings>N</legalProceedings>
        <citizenshipOrOrganization>DE</citizenshipOrOrganization>
        <soleVotingPower>0.00</soleVotingPower>
        <sharedVotingPower>1020300.00</sharedVotingPower>
        <soleDispositivePower>0.00</soleDispositivePower>
        <sharedDispositivePower>1020300.00</sharedDispositivePower>
        <aggregateAmountOwned>1020300.00</aggregateAmountOwned>
        <isAggregateExcludeShares>N</isAggregateExcludeShares>
        <percentOfClass>17.52</percentOfClass>
        <typeOfReportingPerson>PN</typeOfReportingPerson>
      </reportingPersonInfo>
      <reportingPersonInfo>
        <reportingPersonCIK>0001588288</reportingPersonCIK>
        <reportingPersonNoCIK>N</reportingPersonNoCIK>
        <reportingPersonName>Poplar Point Capital GP LLC</reportingPersonName>
        <fundType>WC</fundType>
        <legalProceedings>N</legalProceedings>
        <citizenshipOrOrganization>DE</citizenshipOrOrganization>
        <soleVotingPower>0.00</soleVotingPower>
        <sharedVotingPower>1020300.00</sharedVotingPower>
        <soleDispositivePower>0.00</soleDispositivePower>
        <sharedDispositivePower>1020300.00</sharedDispositivePower>
        <aggregateAmountOwned>1020300.00</aggregateAmountOwned>
        <isAggregateExcludeShares>N</isAggregateExcludeShares>
        <percentOfClass>17.52</percentOfClass>
        <typeOfReportingPerson>HC</typeOfReportingPerson>
      </reportingPersonInfo>
      <reportingPersonInfo>
        <reportingPersonCIK>0001588217</reportingPersonCIK>
        <reportingPersonNoCIK>N</reportingPersonNoCIK>
        <reportingPersonName>Jad Fakhry</reportingPersonName>
        <fundType>WC</fundType>
        <legalProceedings>N</legalProceedings>
        <citizenshipOrOrganization>X1</citizenshipOrOrganization>
        <soleVotingPower>0.00</soleVotingPower>
        <sharedVotingPower>1020300.00</sharedVotingPower>
        <soleDispositivePower>0.00</soleDispositivePower>
        <sharedDispositivePower>1020300.00</sharedDispositivePower>
        <aggregateAmountOwned>1020300.00</aggregateAmountOwned>
        <isAggregateExcludeShares>N</isAggregateExcludeShares>
        <percentOfClass>17.52</percentOfClass>
        <typeOfReportingPerson>IN</typeOfReportingPerson>
      </reportingPersonInfo>
    </reportingPersons>
    <items1To7>
      <item1>
        <securityTitle>Common Stock, par value $0.01 per share</securityTitle>
        <issuerName>Novabay Pharmaceuticals, Inc.</issuerName>
        <issuerPrincipalAddress>
          <com:street1>2000 Powell Street</com:street1>
          <com:street2>Suite 1150</com:street2>
          <com:city>Emeryville</com:city>
          <com:stateOrCountry>CA</com:stateOrCountry>
          <com:zipCode>94608</com:zipCode>
        </issuerPrincipalAddress>
        <commentText>This Amendment is being filed as disclosure to the effect that Novabay Pharmaceuticals, Inc. terminated the voting agreement effective upon the vote.  No other Items noted herein have been updated since previous filed Amendment.

Irrevocable Notice of Termination of Voting Agreement included as Exhibit to this filing.</commentText>
      </item1>
      <item2>
        <filingPersonName>(i) Poplar Point Capital Management LLC ("PPCM"), is a Delaware limited liability company;

(ii) Poplar Point Capital Partners LP ("PPCP"), is a Delaware limited partnership;

(iii) Poplar Point Capital GP LLC ("PPCGP"), is a Delaware limited liability company;

(iv) Jad Fakhry ("Mr. Fakhry"), a United States citizen (collectively with PPCM, PPCP and PPCGP, the "Reporting Persons").

PPCM is the investment manager for PPCP.  PPCGP is the general partner of PPCP.  Mr. Fakhry is the manager of, and owns a controlling interest in, PPCM and PPCGP.</filingPersonName>
        <principalBusinessAddress>The address of the principal business and principal office of each of the Reporting Persons is:

330 Primrose Road, Suite 400
Burlingame, CA 94010</principalBusinessAddress>
        <principalJob>The principal business of the Reporting Persons is investing securities.

The principal occupation of Mr. Fakhry is serving as the Manager of Poplar Point.</principalJob>
        <hasBeenConvicted>During the past five years, none of the Reporting Persons has been convicted in a criminal proceeding (excluding traffic violations or similar misdemeanors).</hasBeenConvicted>
        <convictionDescription>During the past five years, none of the Reporting Persons has been a party to a civil proceeding of a judicial or administrative body of competent jurisdiction and as a result of such proceeding such person was or is subject to a judgment, decree or final order enjoining future violations of, or prohibiting or mandating activities subject to, federal or state securities laws or finding any violation with respect to such laws.</convictionDescription>
        <citizenship>PPCM is a Delaware limited liability company.
PPCP is a Delaware limited partnership.
PPCGP is a Delaware limited liability company.
Mr. Fakhry is a citizen of the United States of America.</citizenship>
      </item2>
      <item3>
        <fundsSource>PPCM directly holds 1,020,300 shares of Common Stock.  Consideration for these assets came from working capital of PPCM.</fundsSource>
      </item3>
      <item4>
        <transactionPurpose>The purpose of the acquisition of the Common Stock is for investment, and the acquisitions of the Common Stock were made in the ordinary course of business.  Given the Reporting Persons' ownership percentage of the Issuer, the Reporting Persons holding of the Common Stock may have the purpose or effect of control.

At this time, the Reporting Persons have no specific plan or proposal to acquire additional Common Stock or dispose of the Common Stock.</transactionPurpose>
      </item4>
      <item5>
        <percentageOfClassSecurities>(i) PPCM
1,020,300
17.52%

(ii) PPCP
1,020,300
17.52%

(iii) PPCGP
1,020,300
17.52%

(iv) Jad Fakhry
1,020,300
17.52%</percentageOfClassSecurities>
        <numberOfShares>(i) PPCM
Sole Voting Power - 0
Shared Voting Power - 1,020,300
Sole Dispositive Power - 0
Shared Dispositive Power - 1,020,300

(ii) PPCP
Sole Voting Power - 0
Shared Voting Power - 1,020,300
Sole Dispositive Power - 0
Shared Dispositive Power - 1,020,300

(iii) PPCGP
Sole Voting Power - 0
Shared Voting Power - 1,020,300
Sole Dispositive Power - 0
Shared Dispositive Power - 1,020,300

(iv) Jad Fakhry
Sole Voting Power - 0
Shared Voting Power - 1,020,300
Sole Dispositive Power - 0
Shared Dispositive Power - 1,020,300</numberOfShares>
        <transactionDesc>In the past 60 days, the following transactions were effected by the Reporting Persons, in normal course of business:
Not applicable.</transactionDesc>
        <listOfShareholders>No other person is known to the Reporting Persons to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, the shares of Common Stock covered by this Statement.</listOfShareholders>
        <date5PercentOwnership>Not applicable.</date5PercentOwnership>
      </item5>
      <item6>
        <contractDescription>Other than as described in this Statement, to the knowledge of the Reporting Persons, there are no contracts, arrangements, understandings or relationships (legal or otherwise) among the Reporting Persons or between the Reporting Persons and any other persons with respect to any securities of the Issuer, including but not limited to transfer or voting of any of the securities, finder's fees, joint ventures, loan or option arrangements, puts or calls, guarantees of profits, division of profits or loss, or the giving or withholding of proxies.</contractDescription>
      </item6>
    </items1To7>
    <signatureInfo>
      <signaturePerson>
        <signatureReportingPerson>Poplar Point Capital Management LLC</signatureReportingPerson>
        <signatureDetails>
          <signature>/s/ Jad Fakry</signature>
          <title>Jad Fakhry, Manager</title>
          <date>10/17/2025</date>
        </signatureDetails>
      </signaturePerson>
      <signaturePerson>
        <signatureReportingPerson>Poplar Point Capital Partners LP</signatureReportingPerson>
        <signatureDetails>
          <signature>/s/ Jad Fakry</signature>
          <title>Jad Fakhry, Manager</title>
          <date>10/17/2025</date>
        </signatureDetails>
      </signaturePerson>
      <signaturePerson>
        <signatureReportingPerson>Poplar Point Capital GP LLC</signatureReportingPerson>
        <signatureDetails>
          <signature>/s/ Jad Fakry</signature>
          <title>Jad Fakhry, Manager</title>
          <date>10/17/2025</date>
        </signatureDetails>
      </signaturePerson>
      <signaturePerson>
        <signatureReportingPerson>Jad Fakhry</signatureReportingPerson>
        <signatureDetails>
          <signature>/s/ Jad Fakry</signature>
          <title>Jad Fakhry</title>
          <date>10/17/2025</date>
        </signatureDetails>
      </signaturePerson>
    </signatureInfo>
  </formData>

</edgarSubmission>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>fp0095930-1_ex991.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 11pt Times New Roman, Times, Serif">

<P STYLE="font: bold 11pt Times New Roman, Times, Serif; margin: 3.95pt 0 0; text-align: center; color: #0B0B0B">IRREVOCABLE NOTICE
OF TERMINATION OF</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center; color: #0B0B0B"><B>VOTING AGREEMENT</B></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 11.8pt 0 0"><B>&nbsp;</B></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; color: #0B0B0B">Poplar Point Capital Management LLC</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; color: #0B0B0B">Poplar Point
Capital Partners LP</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; color: #0B0B0B">Poplar Point Capital GP LLC</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; color: #0B0B0B">Mr. Jad Fakhry</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; color: #0B0B0B">Address: 330 Primrose Road, Suite 400</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; color: #0B0B0B">Burlingame, CA 94010</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; color: #0B0B0B">Attention: Mr. Jad
Fakhry</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; color: #0B0B0B">E-mail: jad@poplarpointcapital.com</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0.15pt 0 0">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; color: #0B0B0B">Mr. David Elliot Lazar</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; color: #0B0B0B">30B, Tower 200 The Towers,</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; color: #0B0B0B">Winston Churchill, San Francisco, Paitilla,</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; color: #0B0B0B">Panama City, Panama. 07196</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; color: #0B0B0B">E-mail: david@activistinvestingllc.com</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0.15pt 0 0 0.5in">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36.55pt; color: #0B0B0B">This
Irrevocable Notice of Termination (this &ldquo;<B>Notice</B>&rdquo;) of the Voting Agreement, dated as of August 19, 2025 (the &ldquo;<B>Voting
Agreement</B>&rdquo;), by and among (a) NovaBay Pharmaceuticals, Inc., a Delaware corporation whose Common Stock is listed for trading
on the NYSE American (the &ldquo;<B>Company</B>&rdquo;), (b) Mr. David Elliot Lazar, an individual (&ldquo;<B>Lazar</B>&rdquo;), and (c)
each of (i) Mr. Jad Fakhry, an individual, (ii) Poplar Point Capital Management LLC, a Delaware limited liability company, (iii) Poplar
Point Capital Partners LP, a Delaware limited partnership, and (iv) Poplar Point Capital GP LLC, a Delaware limited liability company
(each person or entity part of group &ldquo;(c)&rdquo; hereinafter referred to as a &ldquo;<B>Stockholder</B>&rdquo; and, collectively,
the &ldquo;<B>Stockholders</B>&rdquo;), is given as of this 16th day of October, 2025 by the Company. Capitalized terms used herein and
not defined shall have the meaning set forth in the Voting Agreement.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36.55pt; color: #0B0B0B">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36.55pt; color: #0B0B0B">WHEREAS,
the Voting Agreement provides that the term of the Voting Agreement shall commence on the Signature Date and continue for a period of
two (2) years from the Proxy Effective Date, unless terminated by the Company, in the Company&rsquo;s sole discretion;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0.05pt 0 0">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36.55pt; color: #0B0B0B">WHEREAS,
the Stockholders have requested that they have the ability to sell or otherwise transfer all or a portion of the Proxy Shares in the open
market or otherwise once the Approval has been received, which various terms of the Voting Agreement would limit or otherwise interfere
with; and</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36.55pt; color: #0B0B0B">WHEREAS,
to allow for such transferability of the Proxy Shares after the Approval, the Company has determined that it shall terminate the Voting
Agreement in full, with such termination conditioned solely upon, and effective immediately after, the Approval.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36.55pt; color: #0B0B0B">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36.55pt; color: #0B0B0B">NOW,
THEREFORE, pursuant to its rights and powers under Section 10 of the Voting Agreement, the Company hereby provides irrevocable
notice of the termination of the Voting Agreement, with such termination conditioned solely upon, and effective immediately after,
the Approval. Upon termination pursuant to this Notice, the Voting Agreement shall cease to be in effect and all rights and
obligations thereunder, including all grants of proxy, shall terminate in full, effective simultaneously therewith, and all legends
on Proxy Shares with respect thereto shall no longer be required and thereafter promptly removed. Neither this Notice nor the
termination of the Voting Agreement may be revoked, modified or amended without the prior written consent of all parties to the
Voting Agreement. This Notice and all acts and transactions pursuant hereto shall be governed, construed and interpreted in
accordance with the laws of the State of Delaware, without giving effect to principles of conflicts of law. The other parties to the
Voting Agreement are intended third party beneficiaries of this Notice.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 12.55pt 0 0 34.7pt; text-align: justify; text-indent: 36.55pt; color: #0B0B0B"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt"><P STYLE="margin: 0pt; font: 9pt Times New Roman, Times, Serif">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36.55pt; color: #0B0B0B"><FONT STYLE="color: #090909">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36.55pt; color: #0B0B0B"><FONT STYLE="color: #090909">Intending
to be bound hereby, the Company has executed this Notice as of the date first</FONT> <FONT STYLE="color: #1C1C1C">written
above.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0.25pt 0 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 11pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><B>NovaBay Pharmaceuticals, Inc.</B></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%">&nbsp;</TD>
    <TD STYLE="width: 5%">&nbsp;</TD>
    <TD STYLE="width: 35%">&nbsp;</TD>
    <TD STYLE="width: 10%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: left; vertical-align: bottom">By:</TD>
    <TD STYLE="border-bottom: Black 1pt solid"><FONT STYLE="font-family: Sans-Serif; font-size: 9pt; color: Red"><B></B></FONT>/s/ David Lazar</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>Name:</TD>
    <TD>David Lazar</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>Title:</TD>
    <TD>CEO</TD>
    <TD>&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0.05pt 0 0">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0.05pt 0 0">cc:</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0">Abby Brown (abby.brown@squirepb.com)</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0">Ben Fackler (Ben.Fackler@arnoldporter.com)</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0">Daniel Fligsten (dan@fligstenlawgroup.com)</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0">Mr. Avraham Ben-Tzvi (abz@abz-law.com)</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
